One year survival differences of EGFR- and KRAS-mutated advanced non-small cell lung cancer (NSCLC) compared to the wildtype population

被引：0
|
作者：
Boch, Christian [1 ]
Kollmeier, Jens [1 ]
Roth, Andreas [2 ]
Misch, Daniel [1 ]
Streubel, Anna [2 ]
Mairinger, Thomas [2 ]
Bauer, Torsten T. [1 ]
机构：
[1] HELIOS Klinikum Emil von Behring, Pulm Dis Clin Heckeshorn, Dept Pneumol, D-14165 Berlin, Germany
[2] HELIOS Klinikum Emil von Behring, Dept Pathol, D-14165 Berlin, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Lung cancer / Oncology; Biomarkers; Cell biology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
4604
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients
    Boldrin, Elisa
    Nardo, Giorgia
    Zulato, Elisabetta
    Bonanno, Laura
    Polo, Valentina
    Frega, Stefano
    Pavan, Alberto
    Indraccolo, Stefano
    Saggioro, Daniela
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [2] Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
    Sousa, Catarina C.
    Pinto, Josue
    Martins, Natalia
    Teixeira, Sofia
    Magalhaes, Adriana
    Fernandes, Gabriela
    Hespanhol, Venceslau
    Queiroga, Henrique
    Bastos, Helder Novais
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [3] Realities of KRAS-mutated non-small cell lung cancer
    Min, Young Joo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 442 - 442
  • [4] Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Community Practice Setting
    Zhang, L.
    Carter, G. Cuyun
    Beyrer, J.
    Li, L.
    Sheffield, K.
    Muehlenbein, C.
    Boye, M.
    Molife, C.
    Frantz, K.
    John, W.
    Gadgeel, S. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1571 - S1571
  • [5] Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
    Zhang, Yuda
    Zeng, Fanxu
    Peng, Shixuan
    Chen, Yangqian
    Jiang, Wenjuan
    Wang, Zhan
    Deng, Li
    Huang, Zhe
    Qin, Haoyue
    Yan, Huan
    Zhang, Xing
    Zhang, Lin
    Yang, Nong
    Gong, Qian
    Zeng, Liang
    Zhang, Yongchang
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (09) : 743 - 751
  • [6] Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers
    Bagnyukova, Tetyana
    Egleston, Brian L.
    Pavlov, Valerii A.
    Serebriiskii, Ilya G.
    Golemis, Erica A.
    Borghaei, Hossein
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (05): : 1227 - 1239
  • [7] Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)
    Peravali, M.
    Gomes-Lima, C.
    Tefera, E.
    Baker, M.
    Sherchan, M.
    Farid, S.
    Burman, K.
    Constantinescu, F.
    Veytsman, I.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S300 - S301
  • [8] Overall Survival Analysis and Characterization of an EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) Population
    Aguiar, Filipa
    Fernandes, Gabriela
    Queiroga, Henrique
    Machado, Jose Carlos
    Cirnes, Luis
    Moura, Conceicao Souto
    Hespanhol, Venceslau
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (01): : 10 - 17
  • [9] Outcomes of KRAS mutated, EGFR mutated, ALK mutated and wildtype patients in non-small cell lung cancer brain metastases.
    Rauf, Yasmeen
    Tatineni, Vineeth
    Oshea, Patrick Joseph
    Jia, Xuefei
    Peereboom, David M.
    Ahluwalia, Manmeet Singh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Neighborhood disadvantage is associated with KRAS-mutated non-small cell lung cancer risk
    Wing, Sam E.
    Jankowska, Marta M.
    Zou, Xiaoke
    Sosa, Ernesto
    Yang, Jiue-An
    Benmarhnia, Tarik
    Neuhausen, Susan L.
    Nelson, Rebecca
    Salgia, Ravi
    Gray, Stacy W.
    Erhunmwunsee, Loretta
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (08) : 5231 - 5240
12345